Use of the Electronic Health Record to Optimize Antimicrobial Prescribing.


Journal

Clinical therapeutics
ISSN: 1879-114X
Titre abrégé: Clin Ther
Pays: United States
ID NLM: 7706726

Informations de publication

Date de publication:
10 2021
Historique:
received: 28 06 2021
revised: 12 09 2021
accepted: 13 09 2021
pubmed: 15 10 2021
medline: 29 1 2022
entrez: 14 10 2021
Statut: ppublish

Résumé

This review summarizes how interventions in the electronic health record (EHR) can optimize antimicrobial stewardship across the continuum of antimicrobial decision making, from diagnosis of infection to discontinuation of therapy. In addition, opportunities to optimize provider communication and patient education are identified. A narrative review was conducted to identify how interventions in the EHR can influence antimicrobial prescribing behavior. Examples from pediatrics were specifically identified. Interventions were then categorized into high-impact/low-effort, high-impact/high-effort, and low-impact/low-effort groupings based on historical experience. EHR-based interventions can be used for stratifying patients at risk for infection and are useful in identifying patients with new-onset infections. Additional tools include automatically updated antibiograms tailored to specific patient populations, timely authorization of restricted antimicrobials, and more accurate allergy labeling. Medical errors can be reduced and communication between providers can be improved by standardized data fields. Clinical decision support tools can guide appropriate selection of therapy, and visual prompts can reduce unnecessarily prolonged therapy. Benchmarking of antimicrobial use, tailored patient education, and improved communication during transitions of care are enhanced through EHR-based interventions. Prescribing behavior can be modified through a range of interventions in the EHR, including tailored education, alerts, prompts, and restrictions on provider behavior. Further studies are needed to compare the effectiveness of various strategies.

Identifiants

pubmed: 34645574
pii: S0149-2918(21)00381-7
doi: 10.1016/j.clinthera.2021.09.009
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1681-1688

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have indicated that they have no conflicts of interest with regard to the content of this article.

Auteurs

Simon Parzen-Johnson (S)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Kenny D Kronforst (KD)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Rohan M Shah (RM)

Northwestern University, Evanston, Illinois.

Grant R Whitmer (GR)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Tonya Scardina (T)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Meg Chandarraju (M)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Sameer J Patel (SJ)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: sameer.patel@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH